Velsera’s Diagnostics & Discovery Summit
Read more
News
On May 15, 2023 | By The Velsera Clinical and Compliance Team
Velsera Publications
On February 23, 2023 | By The Velsera Clinical and Compliance Team
Addressing barriers in FAIR data practices for biomedical data
Read more
News
On February 7, 2023 | By The Velsera Clinical and Compliance Team
Arima Genomics & Velsera announce partnership
Read more
News
On January 12, 2023 | By The Velsera Clinical and Compliance Team
Velsera launches at JP Morgan Healthcare conference
Read more
Velsera Publications
On October 20, 2021 | By The Velsera Clinical and Compliance Team
NGS-based profiling of key cancer genes in Indian triple-negative breast cancer patients reinforces molecular heterogeneity of the disease
Read more
Client Publications
On February 24, 2021 | By The Velsera Clinical and Compliance Team
Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach
Read more
Velsera Publications
On October 19, 2020 | By The Velsera Clinical and Compliance Team
Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms
Read more
Client Publications
On October 19, 2020 | By The Velsera Clinical and Compliance Team
Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms
Read more
Velsera Publications
On October 14, 2020 | By The Velsera Clinical and Compliance Team
Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers
Read more
Velsera Publications
On June 4, 2020 | By The Velsera Clinical and Compliance Team
Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated RUNX1 versus acute myeloid leukemia with myelodysplasia-related changes with mutated RUNX
Read more
Velsera Publications
On June 1, 2020 | By The Velsera Clinical and Compliance Team
Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
Read more
Client Publications
On May 13, 2020 | By The Velsera Clinical and Compliance Team
Beyond Panel-Based Testing: Exome Analysis Increases Sensitivity for Diagnosis of Genetic Kidney Disease
Read more